Gene and RNA Editing: Revolutionary Approaches to Treating Diseases

Area of Science:

• Molecular Biology
• Biotechnology
• Genetics

Background:

• Gene editing and RNA editing are transformative technologies for precise genetic manipulation.
• CRISPR/Cas systems offer efficient DNA editing, while ADAR and CRISPR-Cas13 enable reversible RNA editing.
• Both technologies hold significant promise for advancing modern medicine and disease treatment.

Purpose of the Study:

• To systematically review the molecular mechanisms and evolution of gene and RNA editing tools.
• To explore their applications in treating nervous system disorders, immune diseases, and cancers.
• To compare technical attributes, discuss ethical considerations, and highlight synergies between gene and RNA editing.

Main Methods:

• Systematic review of molecular mechanisms and technological evolution.
• Focus on applications in neurological, immunological, and oncological diseases.
• Comparative analysis of technical attributes, ethical issues, and synergistic potential.

Main Results:

• CRISPR/Cas systems provide efficient, precise, and cost-effective gene editing.
• RNA editing tools (ADAR, CRISPR-Cas13) offer reversible regulation without genomic integration.
• Delivery efficiency, tissue specificity, and long-term safety are key challenges for clinical translation.

Conclusions:

• Gene and RNA editing technologies are advancing precision medicine.
• Further research is needed to overcome delivery and safety challenges for clinical translation.
• Synergies between gene and RNA editing can reshape disease diagnosis, prevention, and treatment paradigms.